NSNikki M. Schultek

Nikki M. Schultek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nikki M. Schultek has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • George Perry

    University of Texas at San Antonio

    3 shared publications
  • Ruth Itzhaki

    The Alzheimer's Pathobiome Initiative (AlzPI) , Wake Forest, North Carolina

    3 shared publications
  • Brian J. Balin

    Department of Bio‐Medical Sciences Philadelphia College of Osteopathic Medicine Philadelphia Pennsylvania USA

    2 shared publications
  • David B. Corry

    Department of Medicine Baylor College of Medicine Houston Texas USA

    2 shared publications
  • Edward B. Breitschwerdt

    Intracellular Pathogens Research Laboratory Comparative Medicine Institute College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA

    2 shared publications
  • Garth D. Ehrlich

    Center for Genomic Sciences Institute for Molecular Medicine and Infectious Disease Department of Microbiology and Immunology Drexel University College of Medicine Philadelphia Pennsylvania USA

    2 shared publications

Latest Publications

  • Can the COVID-19 pandemic advance neuroinfectious research?

    by Michael R. Duggan, Zena K. Chatila, Lavinia A. Auber, Esther Silberberg, Juan R. Fernandez, Keenan A. Walker, Nikki M. Schultek


  • Open Access

    Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease

    by Praveen Bathini, Emanuele Brai, Brian J Balin, Lynn Bimler, David B Corry, Davangere P Devanand, Richard L Doty, Garth D Ehrlich, William A Eimer, Tamas Fulop, et al.

    Sensory functions of organs of the head and neck allow humans to interact with the environment and establish social bonds. With aging, smell, taste, vision, and hearing decline. Evidence suggests that accelerated impairment in sensory abilities can reflect a shift from healthy to pathological aging, including the development of Alzheimer's disease (AD) and other neurological disorders. While the drivers of early sensory alteration in AD are not elucidated, insults such as trauma and infections can affect sensory function. Herein, we review the involvement of the major head and neck sensory systems in AD, with emphasis on microbes exploiting sensory pathways to enter the brain (the “gateway” hypothesis) and the potential feedback loop by which sensory function may be impacted by central nervous system infection. We emphasize detection of sensory changes as first-line surveillance in senior adults to identify and remove potential insults, like microbial infections, that could precipitate brain pathology.


  • Open Access

    Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease

    by Richard Lathe, Nikki M. Schultek, Brian J. Balin, Garth D. Ehrlich, Lavinia Alberi Auber, George Perry, Edward B. Breitschwerdt, David B. Corry, Richard L. Doty, Robert A. Rissman, et al.

    Microbial infections of the brain can lead to dementia, and for many decades microbial infections have been implicated in Alzheimer's disease (AD) pathology. However, a causal role for infection in AD remains contentious, and the lack of standardized detection methodologies has led to inconsistent detection/identification of microbes in AD brains. There is a need for a consensus methodology; the Alzheimer's Pathobiome Initiative aims to perform comparative molecular analyses of microbes in post mortem brains versus cerebrospinal fluid, blood, olfactory neuroepithelium, oral/nasopharyngeal tissue, bronchoalveolar, urinary, and gut/stool samples. Diverse extraction methodologies, polymerase chain reaction and sequencing techniques, and bioinformatic tools will be evaluated, in addition to direct microbial culture and metabolomic techniques. The goal is to provide a roadmap for detecting infectious agents in patients with mild cognitive impairment or AD. Positive findings would then prompt tailoring of antimicrobial treatments that might attenuate or remit mounting clinical deficits in a subset of patients.


  • Open Access

    Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration

    by Richard Lathe, Nikki M. Schultek, Brian J. Balin, Garth D. Ehrlich, Lavinia Alberi Auber, George Perry, Edward B. Breitschwerdt, David B. Corry, Richard L. Doty, Robert A. Rissman, et al.

    Microbial infections of the brain can lead to dementia, and for many decades microbial infections have been implicated in Alzheimer's disease (AD) pathology. However, a causal role for infection in AD remains contentious, and the lack of standardized detection methodologies has led to inconsistent detection/identification of microbes in AD brains. There is a need for a consensus methodology; the Alzheimer's Pathobiome Initiative aims to perform comparative molecular analyses of microbes in post-mortem brain versus cerebrospinal fluid (CSF), blood, olfactory neuroepithelium, oral/nasopharyngeal tissue, bronchoalveolar, urinary, and gut/stool samples. Diverse extraction methodologies, PCR and sequencing techniques, and bioinformatic tools will be evaluated, in addition to direct microbial culture and metabolomic techniques. The goal is to provide a roadmap for detecting infectious agents in patients with mild cognitive impairment or AD. Positive findings would then prompt tailoring of antimicrobial treatments that might attenuate or remit mounting clinical deficits in a subset of patients.